EQA Scheme
Contact
Virus Genome Detection - HIV-1 Drug Resistance Determination - additional Program for Integrase Inhibitors and Tropism Determination (384)
Samples:
2 samples of 1.5 ml
Sample properties:
Plasma (non-lyophilised)
Additional Information:
IMD Labor Frankfurt;
Institut für Medizinische Virologie, Uniklinikum Frankfurt am Main;
Institut für Klinische und Molekulare Virologie, Uniklinikum Erlangen;
Nationales Referenzzentrum für Papillom- und Polyomaviren, Institut für Virologie, Uniklinik Köln;
Medizinisches Infektiologiezentrum Berlin
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Not subject to Rili-BÄK
Parameters:
Polymerase chain reaction (PCR), other nucleic acid amplification techniques (NAT) and sequencing for HIV-1 drug resistance determination of integrase inhibitors and determination of tropism
Certificate Validity: 24 months
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Oct. (5) |
|---|
| 25.06.2027 |
| 24.08.2027 |
| 01.10.2027 |
EQAS/PT Experts:
Dr. med. Martin Obermeier
MVZ medizinisches Infektiologiezentrum Berlin AG
Oudenarder Strasse 16
13347 Berlin
+49 30-34409104-66
obermeier@mvz-mib.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de